← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2012Last known activity
Sep 26, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT07259343Lead sponsorN/ASep 26, 2025
- NCT07259343OfficialN/ASep 26, 2025
- NCT07259343Sponsor investigatorN/ASep 26, 2025
- NCT01737541Lead sponsorPhase 3Nov 1, 2012
- NCT01737541Overall official - principal investigatorPhase 3Nov 1, 2012
- NCT01737541Reponsible party - principal investigatorPhase 3Nov 1, 2012
Details
- Last known activity
- Sep 26, 2025